DNM1 and chronic kidney disease: We initially observed that clathrin-mediated pathways such as DNM1, DNM2, and SH3GL2 (endophilin) were downregulated in microdissected glomeruli in this CKD cohort, which included glomerular diseases such as membranous nephropathy, lupus nephritis (LN), and diabetic kidney disease (Supplemental Figure 1, A–C; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.142740DS1).